H1B Visa Data for Jeffrey A Feinbloom: Cases Handled,Cases Certified, Approval Rate

We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Jeffrey A Feinbloom has been assisting clients through the H1B Visa process since 2020.

As of 2022, Jeffrey A Feinbloom has succesfully submitted and recieved certification for 64 cases.

Jeffrey A Feinbloom is located in New York, NY, and has represented 24 employers for the H1B Visa Process

67
Cases Handled

64
Cases Certified

95.52%
Approval

Cases Handled by Jeffrey A Feinbloom

Case Number	Case Status	Job Title	Industry Name	Employer Name	Year
I-203-22189-339237	Certified	Securities Commodities And Financial Services Sales Agents	Securities And Commodity Contracts Intermediation And Brokerage	Arlberg Llc	2022
I-203-21055-099315	Certified	Securities Commodities And Financial Services Sales Agents	Securities And Commodity Contracts Intermediation And Brokerage	Arlberg Llc	2021
I-203-22227-416008	Certified	Graphic Designers	Musical Groups And Artists	Tommy Emmanuel Touring Llc	2022
I-203-20289-879401	Certified	Graphic Designers	Musical Groups And Artists	Tommy Emmanuel Touring Llc	2021
I-200-22042-894425	Certified	Graphic Designers	Fresh Fruit And Vegetable Merchant Wholesalers	C Kenneth Imports Inc	2022
I-200-21309-689755	Certified	Medical Scientists Except Epidemiologists	Research And Development In Biotechnology Except Nanobiotechnology	Lexeo Therapeutics Inc	2022
I-200-21237-545602	Certified	Medical Scientists Except Epidemiologists	Research And Development In Biotechnology Except Nanobiotechnology	Lexeo Therapeutics Inc	2021
I-200-24271-371285	Certified	Molecular And Cellular Biologists	Research And Development In Biotechnology Except Nanobiotechnology	Somite Therapeutics	2025
I-200-24170-127194	Certified	Molecular And Cellular Biologists	Research And Development In Biotechnology Except Nanobiotechnology	Somite Therapeutics	2024
I-200-22131-162468	Certified	Molecular And Cellular Biologists	Research And Development In Biotechnology Except Nanobiotechnology	Thymmune Therapeutics Inc	2022